Publishers

Need unique free news content for your site customized to your audience?

Let's Discuss

PRESS RELEASE
By: NewMediaWire
March 19, 2025

Curated TLDR

Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care

By Johnny Rice Benzinga

DETROIT, MICHIGAN - March 19, 2025 (NEWMEDIAWIRE) - Paul Goode, President & CEO, GlucoTrack (NASDAQ: GCTK), was recently a guest on Benzinga’s All-Access.

GlucoTrack is a medical technology company whose two-year implantable Continuous Blood Glucose Monitoring (CBGM) technology provides discreet, accurate, real-time glucose readings. The company’s vision is to create a future where diabetes management is automatic and inconspicuous, empowering people to live boldly and unapologetically.

Learn more here:

https://www.youtube.com/watch?v=xjn-_aLseTc&feature=youtu.be 

Featured photo by Towfiqu barbhuiya on Unsplash.

This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.

This content was originally published on Benzinga. Read further disclosures here.

Blockchain Registration, Verification & Enhancement provided by NewsRamp™

This press release is distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Implantable, Hidden Continuous Glucose Monitoring Could Revolutionize Diabetes Care.

{site_meta && site_meta.display_name} Logo

NewMediaWire

NewMediaWire distributes press releases on behalf of hundreds of publicly traded companies, as well as private corporations, non-profits and other public sector organizations. Founded and staffed by industry veterans, we offer a full complement of services including specialized delivery to financial sites and posting of photos and multimedia content. In addition, NewMediawire offers international and specialized services such as IR websites and industry specific distribution.